Director, Medical Affairs Strategy Team Member; Obesity​/MASH

Director, Medical Affairs Strategy Team Member (Obesity / MASH)
Description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people.

The Director, Medical Affairs Strategy Team Member is responsible to create the Medical strategic framework and prioritized medical tactics to ensure the success of the respective BI product(s) from a Medical Affairs perspective, both prior to and leading up to launch as well as throughout the product lifecycle. This individual will exhibit strong understanding of the therapeutic area, the US healthcare landscape, the relevant clinical practice guidelines, and the emerging scientific data as well as the understanding of the overall TA aspirations and value drivers.

The position holder will translate the TA priorities into an integrated strategic medical plan, tactics, and well-planned budgets that enable the successful medical affairs contribution to BI’s portfolio. In doing so, this individual will play a key role with corporate stakeholders, the US cross-functional partners, and the US Launch Teams in leading the co-creation of aligned strategic medical launch readiness;

and work closely with the clinical development leads to ensure the successful integration of the US Medical insights and efforts where applicable.

The Director, Medical Affairs Strategy Team Member will work with relevant stakeholders to identify the relevant external organized customer channels including the prioritized Health Systems and Payers to drive customized integrated medical plans and executable tactics for this customer segment. The incumbent collaborates cross functionally and within the larger Clinical Development & Medical Affairs (CDMA) department (e.g., Medical Excellence, RWE, etc.)

as well as across the organization (e.g., Marketing, Market Access, Analytics & Insights (A&I), HEOR, Clinical Operations, Patient Services, Legal, Compliance, etc.) and with global counterparts to create, execute, measure, and adapt the Medical Affairs strategy.

• Drives the US collaboration with Corporate TA’s to create a consolidated medical strategy and integrated evidence plan for obesity / MASH products/indications that prioritize innovation and address meaningful gaps internally and externally.
• Leads the indication- or product-specific co-creation with corporate partners of the relevant Global Integrated Business Plans (IBPs) and ensure US strategic business needs are fully integrated into the global IBPs.
• Leads the creation of the respective US Medical Affairs Plans (MAP’s) and implement Launch Excellence tactics in Medical Affairs by driving robust TA medical dialogue with the Corporate TA stakeholders, the US Launch Lead, RWE, FBM, and Medical Excellence.
• Effectively drives the execution of medical tactics, key data release activities, stay abreast of paradigm shifts in clinical practice, and align with BI / CDMA objectives, clinical development pipeline and the evolving US healthcare landscape.
• Identifies and promotes synergies throughout the product lifecycle by influencing the US TAs, Corporate medical, the US TA franchise, Commercial operations, Go-To-Market (GTM), and CDMA leaders.
• Proactively partners with the Medical Affairs Strategy Executive Director to ensure the seamless collaboration with the Clinical Development Lead and the Early Asset TA Lead to facilitate the full integration of the prioritized US clinical practice dynamics into the Clinical Development programs.
• Drives success in TA launches and the timely execution of prioritized evidence generation programs in collaboration with Corporate Medicine TA and US franchise leadership.
• Serves as a key representative in strategic discussions with TAs and CDMA Leadership regarding obesity / MASH products to maximize business opportunities from a medical perspective,…